Clinical Scorecard: Cholangioscopy-Enhanced ERCP Minimizes Radiation Exposure in the Management of Choledocholithiasis: A Retrospective IPTW-Adjusted Analysis
At a Glance
Category
Detail
Condition
Choledocholithiasis
Key Mechanisms
Cholangioscopy-assisted ERCP reduces reliance on fluoroscopy, minimizing radiation exposure.
Target Population
Patients with common bile duct stones undergoing ERCP.
Care Setting
Single-center retrospective study evaluating ERCP techniques.
Key Highlights
Cholangioscopy-assisted ERCP resulted in lower median radiation-dose readings (9.93 mGy vs. 14.64 mGy, p < 0.001).
Reduced risk of high radiation exposure with cholangioscopy assistance (risk ratio 0.301, p = 0.042).
Higher procedure time and hospitalization cost observed with cholangioscopy-assisted ERCP.
Complete duct clearance in one session was 88.0% for cholangioscopy-assisted vs. 94.0% for conventional ERCP.
No significant difference in short-term adverse events between the two groups.
Guideline-Based Recommendations
Diagnosis
ERCP is recommended for duct clearance in patients with choledocholithiasis.
Management
Cholangioscopy-assisted ERCP may improve duct-clearance verification.
Monitoring & Follow-up
Assess for residual stones post-ERCP using cholangioscopy.
Risks
Consider radiation exposure risks associated with fluoroscopy during ERCP.
Patient & Prescribing Data
Patients with bile duct stones treated between June 2024 and June 2025.
Cholangioscopy-assisted ERCP may reduce radiation exposure while maintaining duct clearance.
Clinical Best Practices
Implement cholangioscopy to enhance duct-clearance verification.
Utilize dose-reduction strategies during ERCP to minimize radiation exposure.
